Research Article

Do you really want to improve the results of treatment for acute pneumonia?

Klepikov Igor*

Published: 04/19/2019 | Volume 4 - Issue 1 | Pages: 023-027

Letter to the Editor

The question raised in the title of this letter is a natural consequence of the findings and conclusions that have been growing steadily in recent years regarding the results of treatment for acute pneumonia (АР). If you look at the publications of recent years in this field of medicine, it turns out that one of the main obstacles to progress in improving the results of treatment of this disease is the lack of appropriate methods for determining the pathogen. Thus, the lack of timely diagnostic information about the etiology of the disease excludes the possibility of targeted antibiotic therapy. In recent years, such regrets have become more and more relevant, playing the role of the main explanation for treatment failures .Continuing to narrow the unidirectional view of the problem and to pay attention only to the microbial factor as the main cause of the disease, such views are in fact another illusion, which, even in the case of its hypothetical implementation, will not make significant changes in the overall trend. This statement is easy to verify if you rely on well-known facts, and not use as arguments assumptions and guesses.

Read Full Article HTML DOI: 10.29328/journal.jcicm.1001021 Cite this Article


  1. Davis CP. Normal Flora. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 6. Ref.:
  2. Ref.:
  3. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011; 377: 1264–1275. Ref.:
  4. AJ Morgan, AJ Glossop. Severe community-acquired pneumonia. BJA Education. 2016: 16: 167-172. Ref.:
  5. Ref.:
  6. Jain S, Williams D, Arnold SR, Ampofo K, Bramley AM, et al. Community-Acquired Pneumonia Requieing Hospitalization among US Children. N Engl J Med. 2015; 372: 835-845. Ref.:
  7. Mani CS, Murray DL. Acute Pneumonia and Its Complications. Part II: Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management. SECTION D: Lower Respiratory Tract Infections. In the book: Long SS, Pickering LK, Prober CG. Principles and Practice of pediatric infectious diseases. Edinburgh, New York: Elsevier Churchill Livingstone. 2012; 235-245. Ref.:
  8. Sethi S. Community-Acquired Pneumonia. Merck Manual, professional version. Ref.:
  9. Waterer GW1, Quasney MW, Cantor RM, Wunderink RG. Septic Shock and Respiratory Failure in Community-acquired Pneumonia Have Different TNF Polymorphism Associations. Am J Respir Crit Care Med. 2001; 163: 1599-604. Ref.:
  10. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet.2015; 386(9998): 1097-108. Ref.:
  11. Liapikou A, Rosales-Mayor E, Torres A. The management of severe community acquired pneumonia in the ICU. Expert Rev Respir Med. 2014; 8: 293-303. Ref.:
  12. Vidal A, Santos L. Comorbidities impact on the prognosis of severe acute community-acquired pneumonia. Porto Bio J. 2017: 247-346 Ref.:
  13. Ferrer M1,2, Travierso C1,3, Cilloniz C1,2, Gabarrus A1,2, Ranzani OT1, et al. Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS One. 2018; 13: e0191721. Ref.:
  14. Klepikov I. Acute Pneumonia is More Cardiovascular than Respiratory Disaster. J Emerg Med Care. 2018; 1: 105. Ref.:
  15. Klepikov I. The Meaning of Pulmonary Reflexes in the Pathogenesis of Acute Pneumonia. Intern Med. 2017; 7: 232. Ref.:
  16. Klepikov I. The Role of Cardiovascular Disorders in the Pathogenesis of Acute Pneumonia. J Cardiol & Cardiovasc Ther 2017; 4: 1-3. Ref.:
  17. Klepikov I. First Aid for Aggressive Forms of Acute Pneumonia. EC Pulmonology and Respiratory Medicine. 7.2. 2018; 34-37. Ref.:
  18. Klepikov I. Cupping Therapy as a means of First Aid in Acute Pneumonia. J Clin Case Stu. 2018; 3: Ref.:
  19. Lim TK, Chew MY. Management of severe community acquired pneumonia in the emergency department. J Emerg Crit Care Med. 2018; 2: 2. Ref.:
  20. Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015; 41: 1549-1560. Ref.:
  21. Kim JW, Kim JJ,  Yang HJ, Lim YS, Cho JS, et al. The Prognostic Factors of Pneumonia with Septic Shock in Patients Presenting to the Emergency Department. Korean J Crit Care Med. 2015; 30: 258-264 Ref.:
  22. Klepikov I. The Effect of Intravenous Infusion on the Dynamics of Acute Pneumonia. EC Pulmonology and Respiratory Medicine 4.1. 2017; 15-20. Ref.:
  23. Klepikov I. Acute pneumonia and its purulent and destructive complications in children in the midst of a major industrial centre of Western Siberia. Dissertation for the degree of doctor of medical science. Leningrad. 1989.
  24. Klepikov I. Acute pneumonia: a new look at the old problem. Lambert Academic Publishing. 2007; 3: 36. Ref.: